Paper7627993
Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies.
Ragnhammar P and 5 others. Cancer Immunol Immunother, 1995. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies. Papers, record 7627993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7627993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Anti-Idiotypic | Major topic |
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neoplasm | Major topic |
| Colorectal Neoplasms | Major topic |
| Granulocyte-Macrophage Colony-Stimulating Factor | Major topic |
| Immunotherapy | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Immunoglobulin Isotypes | |
| Immunotoxins | |
| Male | |
| Middle Aged |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1373150 | Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody. | J Clin Immunol | 1992 | https://conductscience.org/library/papers/1373150 | PubMed |
| 2 | 3488949 | Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma. | Hybridoma | 1986 | https://conductscience.org/library/papers/3488949 | PubMed |
| 3 | 7934495 | Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. | Lancet | 1994 | https://conductscience.org/library/papers/7934495 | PubMed |
| 4 | 286328 | Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/286328 | PubMed |
| 5 | 4126980 | Speculations on idiotypes and homobodies. | Ann Immunol (Paris) | 1973 | https://conductscience.org/library/papers/4126980 | PubMed |
| 6 | 3488950 | Phase I clinical trial of CO17-1A monoclonal antibody. | Hybridoma | 1986 | https://conductscience.org/library/papers/3488950 | PubMed |
| 7 | 6582477 | Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6582477 | PubMed |
| 8 | 3874237 | Human immune response to multiple injections of murine monoclonal IgG. | J Immunol | 1985 | https://conductscience.org/library/papers/3874237 | PubMed |
| 9 | 1937495 | Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function? | Hybridoma | 1991 | https://conductscience.org/library/papers/1937495 | PubMed |
| 10 | 7909866 | Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. | Lancet | 1994 | https://conductscience.org/library/papers/7909866 | PubMed |
| 11 | 2787530 | Monoclonal antibody-mediated tumor regression by induction of apoptosis. | Science | 1989 | https://conductscience.org/library/papers/2787530 | PubMed |
| 12 | 8124683 | Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy? | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8124683 | PubMed |
| 13 | 4142565 | Towards a network theory of the immune system. | Ann Immunol (Paris) | 1974 | https://conductscience.org/library/papers/4142565 | PubMed |
| 14 | 2726771 | Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2726771 | PubMed |
| 15 | 2649128 | Monoclonal antibodies for imaging and therapy. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2649128 | PubMed |
| 16 | 3744377 | Trial of therapy with monoclonal antibody 17-1A in pancreatic carcinoma: preliminary results. | Hybridoma | 1986 | https://conductscience.org/library/papers/3744377 | PubMed |
| 17 | 6587365 | Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6587365 | PubMed |
| 18 | 1925633 | The therapeutic use of monoclonal antibodies in colorectal carcinoma. | Semin Oncol | 1991 | https://conductscience.org/library/papers/1925633 | PubMed |
| 19 | 3744381 | Chimeric antibodies with 17-1A-derived variable and human constant regions. | Hybridoma | 1986 | https://conductscience.org/library/papers/3744381 | PubMed |
| 20 | 3878375 | Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody. | J Immunol Methods | 1985 | https://conductscience.org/library/papers/3878375 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17325709 | EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17325709 | PubMed |
| 9806108 | Edrecolomab (monoclonal antibody 17-1A). | Drugs | 1998 | https://conductscience.org/library/papers/9806108 | PubMed |
| 9514045 | Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9514045 | PubMed |
| 8908703 | Monoclonal antibodies in cancer therapy. | Springer Semin Immunopathol | 1996 | https://conductscience.org/library/papers/8908703 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7627993
GET https://conductscience.org/api/papers/v1/7627993/references?page=2